top of page
Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LXM.5
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery...
Laxxon Medical
Feb 43 min read
Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug...
Laxxon Medical
Jan 153 min read
Laxxon Medical Announces Appointment of Two New Members to Board of Directors
New independent directors Christof Bircher and Nneka Ukpai bring significant expertise in business strategy, corporate finance and...
Laxxon Medical
Jan 82 min read
Laxxon Medical to Participate in 27th Annual Needham Growth Conference
NEW YORK, NY / ACCESSWIRE / January 7, 2024 / Laxxon Medical, a leading pharma-technology company pioneering a new generation of...
Laxxon Medical
Jan 71 min read
Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Laxxon Medical Corp., a leading pharma technology platform company focusing on oral drug...
Laxxon Medical
Oct 29, 20243 min read
Laxxon Medical to Present Innovative Oral GLP-1 Agonist including Multi-Compartment Micro-Tablet Form at 2024 BIO-Europe Convention, Aiming to Enhance Compliance for Special Patient Groups
Laxxon is seeking out-licensing opportunities for lead asset LXM.2, or co-developments projects with 3DSP platform technology SPID® at...
Laxxon Medical
Oct 14, 20243 min read
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical , a US-based pharma-technology company pioneering a new generation of...
Laxxon Medical
Oct 9, 20242 min read
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP fa
Laxxon Medical
Oct 2, 20243 min read
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Learn more about Laxxon Medical's groundbreaking 3D printed oral GLP-1 asset, offering an alternative to injections in obesity treatments.
Laxxon Medical
May 22, 20242 min read
Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
Laxxon Medical announced its participation in the 2024 BIO International Convention, to showcase its LXM.2 asset to potential partners.
Laxxon Medical
May 16, 20242 min read
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
Join Dr.Catherine Gatza, our VP of Regulatory Affairs, at the World Orphan Drug Congress USA 2024, in Boston, Massachusetts.
Laxxon Medical
Apr 23, 20242 min read
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
Laxxon Medical, a pioneering pharma-technology company, is set to participate in the 23rd Annual Needham Virtual Health Conference.
Laxxon Medical
Mar 28, 20241 min read
Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs Within Pharmaceutical Dosage Forms
Discover how Laxxon Medical's patent for the sequential release of multiple drugs in pharmaceutical dosage forms revolutionizes healthcare.
Laxxon Medical
Mar 25, 20242 min read
Laxxon Medical to Participate in 26th Annual Needham Growth Conference
Discover the groundbreaking pharmaceutical advancements of Laxxon Medical at the 26th Annual Needham Growth Conference.
Laxxon Medical
Dec 18, 20231 min read
Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
Laxxon Medical announced its attending the 42nd Annual J.P. Morgan Healthcare Conference, the industry's largest healthcare symposium.
Laxxon Medical
Dec 6, 20231 min read
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company's inaugural globalization venture.
Laxxon Medical
Nov 16, 20233 min read
Laxxon Medical to Attend BIO-Europe Munich 2023
Laxxon Medical announced its participation in the 29th annual BIO-Europe Convention, taking place November 6-8, 2023, in Munich, Germany.
Laxxon Medical
Nov 6, 20232 min read
Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
Laxxon Medical announced today their strategic partnership with CU Innovations at the University of Colorado Anschutz Medical Campus.
Laxxon Medical
Jul 18, 20233 min read
3D Screen Printing Technology Enables Fabrication of Oral Drug Dosage Forms
Quick Response (QR) codes have shown enormous potential to improve the flow of information from industry to providers and patients by...
Laxxon Medical
Jul 3, 20233 min read
Laxxon Medical to Participate in 2023 BIO International Convention
Laxxon Medical to Participate in 2023 BIO International Convention
Laxxon Medical
Jun 1, 20231 min read
bottom of page